200
Participants
Start Date
March 10, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
LimpiAD cream 2,5% plus
A topical formulation that contains Hyaluronic Acid conjugated with a bacterial wall fragment of Cutibacterium species (HAc-40) and an emollient base. LimpiAD exerts its post-biotic action through the seizure/ trapping and inactivation of catabolites and / or toxins produced by S. aureus as well as protecting the hydrolipidic film, especially in case of dryness, itching, and, in conditions of altered microbiome
Vehicle
"Vehicle of LimpiAD cream 2.5 % plus which has the qualities of an emollient technically enriched with active ingredients known for their use in AD (plus emollient) - having the same ingredients of LimpiAD 2.5% Plus cream but without the HAc-40 component."
Emollient
Standard emollient used as neutral control, having only a moisturizing and skin barrier action, which represents the basic standard treatment (basic therapy) of atopic dermatitis according to the European Guidelines.
RECRUITING
University of Bari Hospital, Bari
RECRUITING
University of Modena e Reggio Emilia, Modena
RECRUITING
University of Naples Hospital, Naples
TERMINATED
S. Gallicano Hospital, Rome
RECRUITING
University Rome La Sapienza (Hospital Umberto I), Rome
Lead Sponsor
Aileens Pharma SRL
INDUSTRY